Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...
Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...
You must be a Standard 1 Year member to access this content.